The Largest Companies by Market Capitalization, Revenues, Income and Employees within Medical Laboratories Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Ge Healthcare Technologies Inc |
$ 37,168 |
$ 16,399 |
$ 1,729 |
50,000 |
| Iqvia Holdings Inc |
$ 36,706 |
$ 15,315 |
$ 1,405 |
86,000 |
| Koninklijke Philips Nv |
$ 23,524 |
$ 20,349 |
$ -519 |
82,000 |
| Natera Inc |
$ 20,580 |
$ 1,532 |
$ -215 |
3,293 |
| Labcorp Holdings Inc |
$ 19,676 |
$ 11,973 |
$ 437 |
80,000 |
| Hologic Inc |
$ 17,756 |
$ 3,666 |
$ 857 |
6,944 |
| Quest Diagnostics Inc |
$ 17,539 |
$ 9,539 |
$ 890 |
48,000 |
| Icon Plc |
$ 17,438 |
$ 8,120 |
$ 1,237 |
15,950 |
| Incyte Corporation |
$ 13,871 |
$ 4,076 |
$ 32 |
2,524 |
| Exact Sciences Corporation |
$ 11,324 |
$ 2,747 |
$ -214 |
6,600 |
| Medpace Holdings Inc |
$ 11,148 |
$ 2,071 |
$ 366 |
5,900 |
| Charles River Laboratories International inc |
$ 9,796 |
$ 4,061 |
$ 428 |
21,800 |
| Radnet Inc |
$ 5,949 |
$ 1,755 |
$ 49 |
7,872 |
| Syneos Health Inc |
$ 4,485 |
$ 5,419 |
$ 71 |
25,000 |
| Guardant Health Inc |
$ 4,274 |
$ 692 |
$ -512 |
1,779 |
| Veracyte Inc |
$ 3,484 |
$ 408 |
$ -9 |
815 |
| Fortrea Holdings Inc |
$ 1,748 |
$ 3,539 |
$ -286 |
- |
| Caredx Inc |
$ 1,243 |
$ 313 |
$ -144 |
643 |
| Viridian Therapeutics Inc |
$ 1,195 |
$ 0 |
$ -257 |
48 |
| Castle Biosciences Inc |
$ 856 |
$ 312 |
$ 27 |
164 |
| Butterfly Network Inc |
$ 753 |
$ 75 |
$ -99 |
200 |
| Grail Inc |
$ 676 |
- |
$ 0 |
- |
| Fulgent Genetics Inc |
$ 592 |
$ 276 |
$ -172 |
284 |
| Celcuity Inc |
$ 485 |
- |
$ -86 |
58 |
| Maxcyte inc |
$ 456 |
$ 46 |
$ -36 |
- |
| National Research Corporation |
$ 442 |
$ 144 |
$ 27 |
900 |
| Absci Corp |
$ 418 |
$ 4 |
$ -98 |
126 |
| Nano x Imaging Ltd |
$ 418 |
$ 10 |
$ -61 |
- |
| Omniab Inc |
$ 411 |
$ 20 |
$ -63 |
- |
| Somalogic Inc |
$ 393 |
$ 82 |
$ -130 |
- |
| Sera Prognostics Inc |
$ 288 |
$ 0 |
$ -32 |
46 |
| Zymergen Inc. |
$ 251 |
$ 15 |
$ -365 |
- |
| Lightwave Logic Inc |
$ 215 |
- |
$ -22 |
10 |
| Personalis Inc |
$ 211 |
$ 87 |
$ -91 |
- |
| Biodesix Inc |
$ 189 |
$ 66 |
$ -44 |
- |
| Fresh2 Group Ltd |
$ 167 |
$ 2 |
$ -15 |
- |
| Inotiv Inc |
$ 123 |
$ 501 |
$ -101 |
- |
| Exagen Inc |
$ 105 |
$ 56 |
$ 7 |
200 |
| Luna Innovations Inc |
$ 62 |
$ 114 |
$ -2 |
236 |
| Mdxhealth Sa |
$ 61 |
$ 70 |
$ -43 |
- |
| Enzo Biochem Inc |
$ 52 |
- |
$ 45 |
401 |
| Science 37 Holdings Inc |
$ 34 |
- |
$ 77 |
- |
| Akumin Inc |
$ 26 |
$ 738 |
$ -258 |
- |
| American Shared Hospital Services |
$ 23 |
$ 21 |
$ 4 |
51 |
| Onemednet Corporation |
$ 22 |
- |
$ -23 |
- |
| Renalytix Plc |
$ 22 |
$ 2 |
$ -28 |
- |
| Psychemedics Corporation |
$ 16 |
$ 20 |
$ -3 |
90 |
| Bioaffinity Technologies Inc |
$ 11 |
$ 7 |
$ -9 |
11 |
| Centogene N v |
$ 9 |
$ 54 |
$ -40 |
500 |
| Vyant Bio Inc |
$ 6 |
$ 1 |
$ -23 |
- |
| Invitae Corporation |
$ 5 |
$ 482 |
$ -1,441 |
1,500 |
| Bionexus Gene Lab Corp |
$ 5 |
$ 9 |
$ -2 |
- |
| Evolutionary Genomics Inc |
$ 4 |
$ 0 |
$ -2 |
- |
| Delwinds Insurance Acquisition Corp |
$ 4 |
$ 0 |
$ -15 |
- |
| Check cap Ltd |
$ 4 |
- |
$ 18 |
- |
| Dermtech Inc |
$ 3 |
$ 13 |
$ -102 |
- |
| Ispecimen inc |
$ 2 |
$ 10 |
$ -10 |
145 |
| Halberd Corporation |
$ 2 |
- |
$ 0 |
- |
| Opgen Inc |
$ 1 |
$ 2 |
$ -22 |
- |
| Aclarion Inc |
$ 1 |
$ 0 |
$ -6 |
- |
| Advanced Container Technologies Inc |
$ 1 |
$ 5 |
$ -1 |
22 |
| Biocept Inc |
$ 0 |
- |
$ -39 |
135 |
| Grapefruit Usa Inc |
$ 0 |
$ 0 |
$ -4 |
- |
| First Choice Healthcare Solutions Inc |
$ 0 |
$ 87 |
$ -11 |
318 |
| U s Stem Cell Inc |
$ 0 |
$ 0 |
$ -3 |
- |
| Genetron Holdings Ltd |
- |
$ 94 |
$ -118 |
862 |
| Nuoncology Labs Inc |
- |
- |
$ 0 |
- |
| Hh and l Acquisition Co |
- |
- |
$ -1 |
- |
| Burning Rock Biotech Limited |
- |
$ 76 |
$ -92 |
- |
| Total Medical Laboratories Industry |
$ 266,727 |
$ 95,840 |
$ 1,836 |
451,427 |
Recent News from The Largest Companies in Medical Laboratories Industry |
|
Business Update
CareDx Teams Up with TC BioPharm to Enhance Cell Therapy Pharmacokinetics in ACHIEVE Clinical Trial: A Leap Forward in Allogeneic Transplant Monitoring and Risk Prediction In a significant move set against the backdrop of advancing precision medicine, CareDx, Inc. (Nasdaq: CDNA), has entered into a strategic partnership with TC BioPharm aimed at bolsterin...
|
|
|
Product Service News
Revolutionizing Imaging: Nanox.ARC Gains FDA Clearance Amidst Market StrugglesIn a pivotal moment for the medical imaging landscape, NANO-X IMAGING LTD s (Nasdaq: NNOX) Nanox.ARC Imaging System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), positioning itself as a transformative player in the realm of diagnostic technolog...
|
|
|
Business Update
GE HealthCare Leads the Charge: Embracing Sustainable Innovation for a Healthier Future at RSNA 2024 As the medical world gears up for the highly anticipated Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, GE HealthCare (Nasdaq: GEHC) shines a spotlight on its resolute commitment to sustainable innovation. With the gathering s...
|
|
|
Business Update
In a bold step toward redefining the future of medical imaging, GE HealthCare (Nasdaq: GEHC) has announced a significant development in its quest to enhance diagnostic precision: the 510(k) submission to the U.S. Food and Drug Administration for its CleaRecon DL technology. This state-of-the-art, deep learning solution is designed to augment the quality o...
|
|
|
Business Update
Natera, Inc. (NASDAQ: NTRA), a global frontrunner in cell-free DNA and genetic diagnostics, recently cemented its position at the vanguard of prenatal testing with the publication of its latest clinical validation study in the respected journal Obstetrics and Gynecology, also colloquially known as The Green Journal. This milestone marks a significant achi...
|
|
|
Shares
On December 2, 2024, Psychemedics Corporation (Nasdaq: PMD), the leading provider of hair testing for drugs of abuse, announced a dual stock split aimed at restructuring its share capital. The plan includes a 1-for-5,000 reverse stock split followed immediately by a 5,000-for-1 forward stock split, effective at 5:01 p.m. and 5:02 p.m. Eastern Time on Dece...
|
|
|
Product Service News
Expanding Horizons in Breast Cancer Screening: DeepHealth s SmartMammo Gains Wider FDA Clearance DeepHealth, Inc., a prominent player in the realm of AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), has taken a significant stride forward in revolutionizing mammography with the expanded FDA 510(k) clearance of the...
|
|
|
Business Update
Natera Inc., a leading entity in the realm of cell-free DNA and genetic testing, has achieved another significant breakthrough as its Prospera Lung test has obtained Medicare coverage under the Centers for Medicare and Medicaid Services (CMS) Molecular Diagnostics Services (MolDX) Program. This development marks a substantial milestone for single lung tra...
|
|
|
Business Update
A Breath of Fresh Air: Medicare Coverage for Natera s Prospera Lung Test Targets Single Lung Transplants In a significant stride for post-transplant care, Natera, Inc. a pioneer in cell-free DNA and genetic testing announced that its Prospera Lung test has secured coverage from the Centers for Medicare and Medicaid Services (CMS) Molecular Diagnostics Ser...
|
|
|
Business Update
Incyte Unveils Pioneering Oncology and Dermatology Data at Major 2024 Medical Conferences By , CSIMarket.com WILMINGTON, Del. Incyte Corporation (Nasdaq: INCY), a biopharmaceutical company famed for its innovative approach to drug development, is making waves in the medical research community with a series of significant data presentations at promine...
|
|
|
Business Update
Natera, Inc. (NASDAQ: NTRA), a front-runner in the field of cell-free DNA and genetic testing, has recently garnered significant recognition. The company?s co-founder and executive chairman, Matthew Rabinowitz, PhD, was honored as the RandD Leader of the Year for 2024 by RandD World, a testament to Natera s substantial contributions to innovative technolo...
|
|
|
Announcement
MDxHealth: A Struggling Stock Amidst Industry ChallengesMDxHealth, a company specializing in molecular diagnostics for urological diseases, recently announced its participation in the Piper Sandler Healthcare Conference, an event that often showcases promising companies in the healthcare sector. However, in stark contrast to the optimism associated with ...
|
|
|
Management Announcement
IntroductionIn a significant financial maneuver, RadNet, Inc. (NASDAQ: RDNT), a leader in outpatient diagnostic imaging services, has announced the reduction of its credit facility interest rates. This comes hand-in-hand with impressive revenue growth, highlighting RadNet s resilience and tactical positioning in the competitive healthcare landscape. Addit...
|
|
|
Business Update
Decoding the Future: Natera s Signatera? Surges Forward with 100 Peer-Reviewed Milestones In the world of genetics, where every discovery illuminates pathways previously shrouded in mystery, Natera, Inc. stands brilliantly bold. This Austin, Texas-based luminary has announced an achievement that further underscores its reputation as a leader in genetic an...
|
|
|
Clinical Study
The landscape of clinical trials is undergoing a transformative shift fueled by innovative digital strategies. This change is exemplified by Science 37 s remarkable contribution to GlaxoSmithKline s (GSK) Phase 3 rare disease trial. Recent announcements reveal that Science 37 nearly doubled the U.S. enrollment and contributed almost half of the participan...
|
|
|
Product Service News
In a notable development within the healthcare technology sector, Aclarion Inc. announced that its pioneering product, Nociscan, has been highlighted in the RSNA (Radiological Society of North America) edition of Siemens? MAGNETOM Flash. This recognition underscores the growing interest among leading physicians who are increasingly incorporating Nociscan ...
|
|
|
Business Update
In a significant advancement for post-surgical patient care, GE HealthCare (Nasdaq: GEHC) has released findings from a two-phase pilot study conducted in partnership with Cleveland Clinic. The study, published in the peer-reviewed Journal of Clinical Anesthesia, underscores the effectiveness of the Portrait Mobile continuous monitoring solution in enhanci...
|
|
|
Business Update
Luna Innovations Faces Compliance Challenges as Nasdaq Issues Late Filing NoticeIn a significant development, Luna Innovations Incorporated (Nasdaq: LUNA), a leader in advanced fiber optic-based technology, has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC. Dated November 14, 2024, this written notice outline...
|
|
|
Business Update
Luna Innovations Faces Nasdaq Warning Amidst Administrative Delays In a recent development that has caught the attention of investors and analysts, Luna Innovations Incorporated (Nasdaq: LUNA), a prominent figure in advanced fiber optic-based technology, disclosed receiving a notice from the Nasdaq Stock Market. The notification, delivered on November 14,...
|
|
|
Product Service News
In a significant development in the field of autoimmune disease diagnostics, Exagen Inc. recently announced the successful validation and regulatory submission for new biomarkers related to lupus and rheumatoid arthritis. This breakthrough comes through their innovative AVISE CTD platform, designed to enhance diagnostic clarity for clinicians treating pat...
|
|
|
Business Update
In an era where innovation stands at the forefront of healthcare, GE HealthCare has made significant strides with its recent FDA 510(k) clearance for the SIGNA MAGNUS, a cutting-edge head-only MRI system. This high-performance, 3.0T scanner presents a pivotal advancement in the realm of neuroimaging, with the potential to transform the diagnosis and under...
|
|
|
Management Announcement
IntroductionMaxCyte Inc. proudly commemorates 25 years of innovation in the field of cell engineering, a milestone marked by numerous advancements in cell and gene therapy since its inception in 1999. Despite its celebrated history, the company faces challenges, including a significant net loss reported for the second quarter of 2024. However, its recent ...
|
|
|
Business Update
In an era when healthcare demands are burgeoning, one crucial profession is experiencing a startling shortfall that could threaten patient care: radiologic technologists (rad techs). In response to this pressing scenario, GE HealthCare has launched a significant new initiative in collaboration with AMN Healthcare, aimed at addressing the critical shortage...
|
|
|
Business Update
WALTHAM, Mass. Viridian Therapeutics, Inc. (NASDAQ: VRDN), a pioneering biotechnology firm dedicated to the discovery and development of innovative medicines for serious and rare diseases, announced its financial results and business progress for the third quarter ending September 30, 2024. The report highlighted significant operational achievements acr...
|
|
|
Business Update
Harnessing the Power of Artificial Intelligence: GE HealthCare and RadNet s Strategic Partnership in Medical Imaging In a world where the boundaries of technology continually evolve, GE HealthCare and RadNet have joined forces in a dynamic collaboration aimed at revolutionising the medical imaging landscape. This strategic venture was recently unveiled in...
|
|
|
Partnership
Collaborative Efforts to Transform Imaging and Promote Healthcare Equity: GE HealthCare, RadNet, and Community Initiatives Transformative Partnership in Imaging SystemsOn November 11, 2024, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a prominent subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a groundbreaking strategic collaboration to reshap...
|
|
|
Business Update
In a striking recognition of innovation in healthcare, Butterfly Network, Inc. (NYSE: BFLY), a pioneering digital health company, recently celebrated its third-generation handheld ultrasound device, the Butterfly iQ3, winning the prestigious Best Medical Technology Award at the 2024 Prix Galien USA Awards. This accolade, bestowed by the Galien Foundation,...
|
|
|
Business Update
In a groundbreaking moment for medical technology, Butterfly Network?s iQ3 has been recognized as the Best Medical Technology at the 2024 Prix Galien USA Awards. This accolade establishes Butterfly Network, Inc. (NYSE: BFLY), as a frontrunner in the healthcare industry, highlighting its transformative capabilities through portable, semiconductor-based ult...
|
|
|
Business Update
Butterfly Network, Inc. (NYSE: BFLY), a pioneering digital health company, has etched its mark in the medical technology landscape by winning the coveted Best Medical Technology Award at the 2024 Prix Galien USA Awards. This prestigious accolade highlights Butterfly s groundbreaking work in transforming healthcare through state-of-the-art portable ultraso...
|
|
|
Business Update
In the rapidly evolving landscape of digital health technology, Butterfly Network, Inc. (NYSE: BFLY) is making significant strides that position the company as a key player in the industry. Their commitment to transforming care through portable, high-quality ultrasound technology is underscored by a series of recent announcements that highlight both their...
|
|
|
|
|
|
